Lee, JY Park, WH Cho, MK Yun, HJ Chung, BH Pak, YK Hahn, HG Cheon, SH 2024-01-21T05:36:19Z 2024-01-21T05:36:19Z 2021-09-03 2005-02 0253-6269 https://pubs.kist.re.kr/handle/201004/136789 The synthesis and structure-activity relationships of a novel series of substituted quercetins that activates peroxisome proliferator-activated receptor gamma (PPARgamma) are reported. The PPARgamma agonistic activity of the most potent compound in this series is comparable to that of the thiazolidinedione-based antidiabetic drugs currently in clinical use. English PHARMACEUTICAL SOC KOREA ANTIHYPERGLYCEMIC AGENTS HYPOGLYCEMIC AGENTS THIAZOLIDINEDIONE ADD-3878 Design and synthesis of novel antidiabetic agents Article 10.1007/BF02977705 1 ARCHIVES OF PHARMACAL RESEARCH, v.28, no.2, pp.142 - 150 ARCHIVES OF PHARMACAL RESEARCH 28 2 142 150 scie scopus kci ART000998292 000227350300002 2-s2.0-21844433253 Chemistry, Medicinal Pharmacology & Pharmacy Pharmacology & Pharmacy Article ANTIHYPERGLYCEMIC AGENTS HYPOGLYCEMIC AGENTS THIAZOLIDINEDIONE ADD-3878 antidiabetic agents quercetin thiazolidinedione malonate